Rapid Meningitis Test

The BioFire ME Panel is an FDA-cleared syndromic test that targets 14 of the most common bacterial, viral, and fungal causes of central nervous system infections.

Every Minute Counts When it Comes to Meningitis.

Patients with suspected meningitis are treated empirically pending diagnostic results.3,4 This can mean lengthy hospitalizations and unnecessary antimicrobial use, all of which add to the overall cost of care.

Time to diagnosis is critical. Bacterial meningitis can be fatal in healthy people in 24 to 48 hours.2 The right treatment depends on quick identification of the pathogen as bacterial, viral, or yeast.

Increase diagnostic yield

2.7x overall increase for adult patients5
2.3x overall increase for pediatric patients6
Shorten time to diagnosis*

3.3-day reduction for adult patients7
4-day reduction for pediatric patients4
*From time of initial presentation to the Emergency Department
Impact antimicrobial therapy

2-day reduction in both acyclovir and antibiotic duration for adult patients8
2-day reduction in both acyclovir and antibiotic duration for pediatric patients9
Shorten hospital stays

2.2-day reduction in length of stay for adult patients8
2-day reduction in length of stay for pediatric patients4